Breast Augmentation: A Review

Overview · Recovery · Preparation · Complications · Techniques · Controversies · Evidence · Related articles · question library below

Breast augmentation enlarges or restores the breast using implants or the patient's own fat, and it remains one of the world's most performed cosmetic operations, with roughly 1.6 million procedures in the most recent ISAPS global survey. It is also one of the best studied: the United States FDA required manufacturers to follow thousands of implant patients for a decade, producing long term data most procedures lack.

The single most useful framing from that data: an implant is a device with a maintenance schedule, not a one time purchase. In the FDA core studies, between roughly 20 and 40 percent of primary augmentation patients had some reoperation within eight to ten years, for reasons ranging from size change requests to capsular contracture, and about one in five Allergan augmentation patients had implants removed by year ten. Satisfaction is nonetheless consistently high when expectations are set correctly, which is what this page tries to do.

The operation

Augmentation typically takes one to two hours under general anesthesia as an outpatient. An incision (most commonly in the fold under the breast) creates a pocket either partly under the chest muscle or over it, the implant or graft is placed, and the incisions are closed. Fat transfer augmentation instead harvests fat by liposuction and grafts it, trading device risks for volume limits: fat transfer to the breast (Grade B).

Augmentation recovery is among the faster ones in cosmetic surgery. Expect soreness and tightness for several days, most patients back at desk work within about a week, lower body exercise around two to three weeks, and chest loading last, commonly four to six weeks, especially with under the muscle placement, which trades a tighter early recovery for its long term advantages. Implants ride high and firm at first and settle over weeks to months; final softness and position judgments belong at three to six months.

Two practical notes with evidence behind them: sleep on your back with gentle support early, and treat any surgeon specific instruction (bands, massage, garments) as the controlling guidance, because protocols genuinely differ by implant and plane. General healing adjuncts are covered in Recovery After Cosmetic Surgery and scar care, which matters at the fold incision, in Scar Management (Grade A fundamentals).

The general preparation evidence applies in full: nicotine cessation four to six weeks (the Grade A file in Preoperative Preparation), holding blood thinning supplements one to two weeks (supplements, Grade C), and disclosing GLP-1 drugs (Ozempic and surgery, Grade B).

Decisions to settle before surgery day

• Implant fill and profile: the silicone versus saline trade offs are real and personal: silicone versus saline (Grade B).
• Plane: under versus over the muscle changes animation, rippling, mammography, and recovery: the placement evidence (Grade B).
• Sizing: sizers and 3D imaging help, but communicate in goals and photographs, not cup sizes, which no manufacturer standardizes.
• Life planning: pregnancy and breastfeeding intentions belong in the consultation; the reassuring evidence is that breastfeeding is usually possible with implants (Grade A).

Questions that separate surgeons

Board certification; annual augmentation volume; photographs of healed results on chests shaped like yours; their personal reoperation and capsular contracture rates; which implant registry and warranty applies; and the follow up imaging plan for silicone devices.

Short term surgical complications are uncommon; the defining risks of augmentation are the long horizon ones, and the FDA core studies quantified them honestly.

The named conditions

• Capsular contracture: tightening of the natural scar capsule around the implant, the leading medical cause of reoperation; risk accumulates over years and varies with device, plane, and technique.
• Rupture: silent in silicone devices, which is why periodic imaging surveillance is recommended; how long implants last (Grade C).
• BIA-ALCL: a rare lymphoma associated primarily with textured surfaces: what BIA-ALCL is (Grade C on incidence).
• Breast implant illness: systemic symptoms some patients attribute to implants; the causal evidence is genuinely mixed and reported that way: the BII evidence (Grade B).
• Screening interaction: mammography remains effective with displacement views: implants and mammograms (Grade B).

The full long horizon file lives in Breast Implant Safety. Early warning signs deserving a call: one sided swelling or pain, fever, spreading redness; and our emergency guidance for systemic symptoms.

The four implant decisions, fill, shape and size, pocket, and incision, have a dedicated hub: Breast Implant Choices. The essentials follow.

Fill: silicone versus saline

Modern cohesive silicone feels more tissue like and ripples less; saline uses a smaller incision, signals rupture by simple deflation, and costs less. Neither is safer in a way the long term data crowns: the comparison evidence (Grade B) frames it as trade offs by priority, not a ranking.

Plane: under versus over the muscle

Submuscular placement lowers visible rippling and may ease mammography at the cost of animation deformity and a tougher first week; subglandular placement recovers faster and avoids animation at the cost of more visible edges in thin tissue. The evidence, reviewed in the placement answer (Grade B), supports matching plane to tissue coverage rather than declaring a winner; dual plane hybrids exist precisely because both have merits.

Incisions

Inframammary (under the fold) offers the most control and the strongest contracture data in several series; periareolar trades a subtle scar position for passage near ducts; transaxillary hides the scar in the armpit with instrument trade offs. The abandoned routes tell their own story: transumbilical (TUBA) augmentation remains niche for cited reasons rather than fashion (Grade C).

Fat transfer

Grafted fat avoids device surveillance entirely, at the price of modest size change, partial graft resorption, and occasional oil cysts or calcifications that imaging must learn to read: the fat transfer evidence (Grade B). Hybrid approaches combine a smaller implant with fat for edge softening.

Texture, BIA-ALCL, and the market's answer

Textured implants dominated some markets until their association with BIA-ALCL drove recalls and a global shift back to smooth devices. The honest state: absolute risk remains rare, varies by device generation, and the field continues refining incidence estimates. Knowing your implant's identity is the durable lesson.

Breast implant illness

Few topics divide patients and literature more sharply. Symptoms are real; attribution is unresolved; some patients improve after explantation while trial grade causal evidence is lacking. Our BII answer holds that line deliberately, and dismissing patients and overclaiming causation are both failures of evidence.

The 10 year replacement myth

"Implants must be replaced every ten years" is folklore; no such schedule exists. What exists is a rising probability of reoperation over decades and a surveillance recommendation for silicone. The truthful version is maintenance, not expiry: the lifespan evidence.

Rapid recovery marketing

Twenty four hour recovery protocols reflect real advances (gentle technique, no drains, motion early) and also marketing gloss on an operation whose deep recovery still takes weeks. Ask what the protocol actually changes and what it merely renames.

• Grade A: breastfeeding feasibility with implants; general preparation fundamentals (nicotine, scar care).
• Grade B: FDA core study long term outcomes (reoperation roughly 20 to 40 percent by 8 to 10 years; removal 7 to 21 percent by manufacturer; rupture roughly 10 to 14 percent in imaging cohorts); silicone versus saline and plane trade offs; mammography interaction; fat transfer trade offs; the mixed BII literature.
• Grade C: implant lifespan framing; BIA-ALCL incidence precision; incision route comparisons; TUBA.

External anchors include the FDA silicone implant core study update and manufacturer ten year core study publications; every graded claim links to a cited answer below.

Breast Implant Choices · Breast Implant Safety · Breast Lift · Breast Reduction · Recovery · Preoperative Preparation · Complications · Breast augmentation self-assessment.

The complete question library for this topic follows below.